India’s leading super speciality hospital Apollo has joined hands with RMS Regrow, a cell therapy technology specialist, to offer new cell therapy products for orthopedic patients suffering from bone and cartilage problems.
The products Ossron and Chondron have been launched to tap the huge potential of orthopedic market with respect to sports injuries, accidents and alternate to hip replacements and knee replacements. Ossron for bone treatment is the first such product in the world, while Chondron for cartilage treatment is the first in India and third in the world.
The two companies have tied up to make available the treatment therapy through all Apollo Hospitals, Apollo Spectra Hospitals and Apollo clinics in India.
Ossron and Chondron have been launched following over eight years of dedicated research, several clinical trials and evaluation studies.
Established in the year 2009, Regenerative Medical Services Pvt Ltd is the first Indian biotechnology company to introduce cutting-edge technology platform for regenerative medicine in India.
